AR042950A1 - Proceso para sintetizar compuestos de [(2-piridinil sustituido)metil) sulfinil benzimidazol sustituido - Google Patents
Proceso para sintetizar compuestos de [(2-piridinil sustituido)metil) sulfinil benzimidazol sustituidoInfo
- Publication number
- AR042950A1 AR042950A1 ARP040100251A ARP040100251A AR042950A1 AR 042950 A1 AR042950 A1 AR 042950A1 AR P040100251 A ARP040100251 A AR P040100251A AR P040100251 A ARP040100251 A AR P040100251A AR 042950 A1 AR042950 A1 AR 042950A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- groups
- compound
- group
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Manufacturing & Machinery (AREA)
- Ceramic Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Structural Engineering (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un proceso para sintetizar compuestos de [(2-piridinil sustituido)metil]sulfinil benzimidazol sustituido de la fórmula (1), fórmula (2), fórmula (39 y fórmula (4), donde el grupo R, representas un alquilsulfonilo, arilsulfonilo, arilsulfonilo sustituido, heteroarilsulfonil, heteroarilsulfonil sustituido, o un grupo bencilo sustituido con R1, R2, R3 y R4, en donde, R1 y R2 son independientemente H, un grupo alquilo di- o tri- sustituido de cadena recta o ramificada di o trivalente de 1 a 12 carbonos, incluyendo 1 o dos grupos R5, o un esqueleto de hidrocarburo saturado de cadena recta o ramificada que no tiene más de 12 C incluyendo 1 o dos grupos R5 y opcionalmente, posteriormente, que incluye uno a tres grupos X donde X está independientemente seleccionado del grupo que consiste de -O-, -S-, -NR6-, -NHCO-, -CONH-, -CONHCO-, -COO-, -OCO- y un grupo fenil di-sustituido que puede, opcionalmente, ser sustituido con uno o dos átomos de halógeno, o con uno o dos grupos R3, o el grupo R5 está directamente unido, sin un grupo R1 o R2 interviniente, al anillo de fenilo, en las fórmula 1a o 2a; R3 y R4 son independientemente H, alquilo de 1 a 3 C, fluoralquilo de 1 a 3 C, O-alquilo de 1 a 3 C, o-fluoralquilo de 1 a 3 C, S-alquilo de 1 a 3 C, S-fluoroalquilo de 1 a 3 C; R5 es independientemente H, COOH; R4 es H o alquilo de 1 a 3 C; con la salvedad que al menos uno de los grupos R1 y R2 no sea H, y al menos uno de R5 no sea H y no más de dos grupos R5 sean COOH donde el compuesto incluye al menos uno pero no más que dos grupos -COOH, el proceso caracterizado porque comprende los pasos de: (1) el anillo cerrando un compuesto de la fórmula (5) para formar un compuesto e la fórmula (6); (2) reaccionando el compuesto de la fórmula (6) con un reactivo de la fórmula (7) para formar un compuesto de la fórmula (8); (3) y oxidar el compuesto de la fórmula (8) para formar el compuesto seleccionado de las fórmulas (1) hasta la (4), en donde XO representa CH3O o HF2CO unido a la posición 4 o 5 del compuesto de la fórmula (5) y a la posición 5 o la posición 6 de la fracción bencimidazola de las fórmulas (1) hasta la (4), y X1, X2 y X3 representan tanto (a) metilo, metoxi y grupos metilo unidos respectivamente a las posiciones 3, 4 y 5 del anillo de piridina, o (b) X1 es metoxi unido a la posición 3 de la fracción de piridina, X2 es metoxi unido a la posición 4 de la fracción de piridina, y X3 es H. El proceso es útil para sintetizar las prodrogas isoméricamente puras de los inhibidores de la bomba de protón. En una realización preferida, se revelan los métodos para sintetizar los isómeros de las prodrogas omeprazola y pantoprazola.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48734003P | 2003-07-15 | 2003-07-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR042950A1 true AR042950A1 (es) | 2005-07-06 |
Family
ID=34193068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040100251A AR042950A1 (es) | 2003-07-15 | 2004-01-28 | Proceso para sintetizar compuestos de [(2-piridinil sustituido)metil) sulfinil benzimidazol sustituido |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7294716B2 (es) |
| EP (1) | EP1644352A1 (es) |
| JP (1) | JP2007521314A (es) |
| KR (1) | KR20060041224A (es) |
| CN (1) | CN1823058A (es) |
| AR (1) | AR042950A1 (es) |
| AU (1) | AU2004264401A1 (es) |
| BR (1) | BRPI0412590A (es) |
| CA (1) | CA2532104A1 (es) |
| IL (1) | IL172623A0 (es) |
| MX (1) | MXPA06000410A (es) |
| NZ (1) | NZ544173A (es) |
| PL (1) | PL379542A1 (es) |
| TW (1) | TW200502232A (es) |
| WO (1) | WO2005016917A1 (es) |
| ZA (1) | ZA200510221B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05013316A (es) * | 2003-06-10 | 2006-03-17 | Teva Pharma | Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol. |
| US20050075371A1 (en) * | 2003-10-03 | 2005-04-07 | Allergan, Inc. | Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
| BRPI0507837A (pt) * | 2004-02-18 | 2007-07-10 | Allergan Inc | métodos e composições para a administração intravenosa de compostos relacionados a inibidores de bomba de prótons |
| US7914681B2 (en) * | 2004-05-28 | 2011-03-29 | Jms Co. | Hemodialyzer capable of intermittent repetition of infusion and water removal operation |
| WO2007073301A1 (en) * | 2005-12-23 | 2007-06-28 | Astrazeneca Ab | Benzoimidazole derivatives as prodrugs of proton pump inhibitors |
| US20070265311A1 (en) * | 2006-01-10 | 2007-11-15 | Rubino Mark P | Therapeutic Salt Compositions and Methods |
| EP2294064A4 (en) * | 2008-07-07 | 2011-10-05 | Hetero Research Foundation | PROCESS FOR PURIFYING RABEPRAZOLE-SODIUM |
| US8927559B2 (en) | 2010-10-11 | 2015-01-06 | Merck Sharp & Dohme Corp. | Quinazolinone-type compounds as CRTH2 antagonists |
| US9290453B2 (en) | 2010-12-23 | 2016-03-22 | Merck Sharp & Dohme Corp. | Quinolines and aza-quinolines as CRTH2 receptor modulators |
| EP2661428B1 (en) | 2010-12-23 | 2017-06-07 | Merck Sharp & Dohme Corp. | Quinoxalines and aza-quinoxalines as crth2 receptor modulators |
| CN103232389A (zh) * | 2013-05-08 | 2013-08-07 | 浙江新三和医药化工股份有限公司 | 2-氯甲基-4-甲氧基-3,5-二甲基吡啶盐酸盐的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| SE8300736D0 (sv) * | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
| IL75400A (en) | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
| JPS6150978A (ja) | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
| FI90544C (fi) | 1986-11-13 | 1994-02-25 | Eisai Co Ltd | Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi |
| SE9301830D0 (sv) | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
| US6093734A (en) | 1998-08-10 | 2000-07-25 | Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin | Prodrugs of proton pump inhibitors |
| AU752292B2 (en) * | 1998-08-10 | 2002-09-12 | Regents Of The University Of California, The | Prodrugs of proton pump inhibitors |
| US6348032B1 (en) * | 1998-11-23 | 2002-02-19 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with benzimidazole derivatives |
| US6599167B2 (en) * | 2000-09-27 | 2003-07-29 | Glenn Waltz | Game call holder and amplifying device |
| BR0312802A (pt) * | 2002-07-19 | 2005-04-19 | Michael E Garst | Pró-drogas de inibidores de bombas de próton |
-
2004
- 2004-01-15 WO PCT/US2004/001154 patent/WO2005016917A1/en active Application Filing
- 2004-01-15 EP EP04702576A patent/EP1644352A1/en not_active Withdrawn
- 2004-01-15 NZ NZ544173A patent/NZ544173A/en unknown
- 2004-01-15 AU AU2004264401A patent/AU2004264401A1/en not_active Abandoned
- 2004-01-15 CA CA002532104A patent/CA2532104A1/en not_active Abandoned
- 2004-01-15 MX MXPA06000410A patent/MXPA06000410A/es unknown
- 2004-01-15 BR BRPI0412590-8A patent/BRPI0412590A/pt not_active IP Right Cessation
- 2004-01-15 CN CNA2004800204889A patent/CN1823058A/zh active Pending
- 2004-01-15 JP JP2006520146A patent/JP2007521314A/ja active Pending
- 2004-01-15 PL PL379542A patent/PL379542A1/pl unknown
- 2004-01-15 KR KR1020067000776A patent/KR20060041224A/ko not_active Application Discontinuation
- 2004-01-27 TW TW093101731A patent/TW200502232A/zh unknown
- 2004-01-28 AR ARP040100251A patent/AR042950A1/es unknown
- 2004-07-13 US US10/891,317 patent/US7294716B2/en not_active Expired - Fee Related
-
2005
- 2005-12-15 ZA ZA200510221A patent/ZA200510221B/en unknown
- 2005-12-15 IL IL172623A patent/IL172623A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06000410A (es) | 2006-03-17 |
| WO2005016917A1 (en) | 2005-02-24 |
| AU2004264401A1 (en) | 2005-02-24 |
| BRPI0412590A (pt) | 2006-09-19 |
| TW200502232A (en) | 2005-01-16 |
| CN1823058A (zh) | 2006-08-23 |
| PL379542A1 (pl) | 2006-10-02 |
| CA2532104A1 (en) | 2005-02-24 |
| JP2007521314A (ja) | 2007-08-02 |
| EP1644352A1 (en) | 2006-04-12 |
| US20050038076A1 (en) | 2005-02-17 |
| ZA200510221B (en) | 2006-12-27 |
| KR20060041224A (ko) | 2006-05-11 |
| IL172623A0 (en) | 2006-04-10 |
| NZ544173A (en) | 2009-04-30 |
| US7294716B2 (en) | 2007-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR042950A1 (es) | Proceso para sintetizar compuestos de [(2-piridinil sustituido)metil) sulfinil benzimidazol sustituido | |
| NZ734896A (en) | Novel 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same | |
| AR055676A1 (es) | Derivados imidazopiridina | |
| AR043436A1 (es) | Tetrahidroisoquinolinas sustituidas para uso como moduladores 5-ht6 | |
| NO20060670L (no) | N3-substituerte imidazopyridin C-kit inhibitorer | |
| ES2308299T3 (es) | Tiadiazoles como ligandos de receptores de cxc-y cc-quimioquinas. | |
| EA200801969A1 (ru) | Производные пиперидинил-, индолил-, пиридинил-, морфолинил- и бензимидазолилмочевины как ингибиторы растворимой эпоксидгидролазы для лечения гипертонии, воспалений и других заболеваний | |
| NO20060665L (no) | N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer | |
| CY1114932T1 (el) | Αντιπαρασιτικοι παραγοντες | |
| EA200701470A1 (ru) | Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений | |
| NO20060664L (no) | N-substituerte benzimidazolyl C-kit inhibitorer | |
| EA201000437A1 (ru) | Способ получения растворимых в воде продуктов гидролиза целлюлозы | |
| AR101815A1 (es) | Compuestos y composiciones como inhibidores de quinasa | |
| RU2012129930A (ru) | Соли тиазолидиндиона со сниженным сродством к ppar для лечения нарушений обмена веществ | |
| ATE283253T1 (de) | Substituierte aminopropoxyarylderivate als lxr agonisten | |
| AR048875A1 (es) | Un proceso para preparar montelukast y compuestos intermedios para el mismo | |
| ES2526902T3 (es) | Procesos de producción de inhibidores de la girasa y topoisomerasa IV | |
| EA201070839A1 (ru) | Новые производные ацилцианопирролидинов | |
| RU2005105564A (ru) | Производные бензимидазола и их применение в качестве пролекарств ингибиторов протонного насоса | |
| CO5650235A2 (es) | Derivados de imidazol | |
| AR047810A1 (es) | Proceso quimico | |
| EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
| JP2008540333A5 (es) | ||
| CY1107028T1 (el) | Παραγωγα ινδανυλ-πιπεραζινων μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
| ES2291722T3 (es) | Aminoalcoxiindoles como ligandos 5-ht6-receptores para el tratamiento de transtornos del snc. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |